Man Yan Hui - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Man Yan Hui

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Critical Reviews in Oncology/Hematology|November 24, 2025

Chimeric antigen receptor-based cellular therapy for T-cell malignanciesSile Li, Yuanxin Li, Man Yan Hui, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 26, 2026

Generation of CCR4/CD7 Bispecific CAR-T Cells Resistant to Fratricide and ExhaustionSile Li, Yuanxin Li, Asif Rashid, et al.

Cytotherapy|May 27, 2026

Quadruple immunotherapy with allogeneic natural killer cell infusion for recurrent neuroblastomaChi Hang Wong, Man Yan Hui, Wilson Yau Ki Chan, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Critical Reviews in Oncology/Hematology|November 24, 2025

Chimeric antigen receptor-based cellular therapy for T-cell malignanciesSile Li, Yuanxin Li, Man Yan Hui, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 26, 2026

Generation of CCR4/CD7 Bispecific CAR-T Cells Resistant to Fratricide and ExhaustionSile Li, Yuanxin Li, Asif Rashid, et al.

Cytotherapy|May 27, 2026

Quadruple immunotherapy with allogeneic natural killer cell infusion for recurrent neuroblastomaChi Hang Wong, Man Yan Hui, Wilson Yau Ki Chan, et al.

Pageof 1